Loading chat...
NY A05392
Bill
Status
2/13/2025
Primary Sponsor
Linda Rosenthal
Click for details
AI Summary
-
Expands the definition of "epinephrine device" in New York law to include FDA-approved nasal spray products in addition to traditional auto-injectors for treating anaphylaxis
-
Updates terminology throughout the Public Health Law, Education Law, and Insurance Law by replacing "epinephrine auto-injector" with the broader term "epinephrine device"
-
Maintains existing authorization for eligible entities (schools, camps, emergency services, public venues, restaurants) to purchase, possess, and administer epinephrine devices with proper training
-
Preserves insurance coverage requirements for medically necessary epinephrine devices, with out-of-pocket costs capped at $100 annually for insured individuals
-
Continues allowing trained school personnel to administer epinephrine devices in emergencies and permitting students with allergies to carry prescribed devices on school property
Legislative Description
Defines epinephrine device as a single-use device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.
Last Action
substituted by s7807a
6/12/2025